This article has Open Peer Review reports available.
Evaluation of the immunogenicity and safety of different doses and formulations of a broad spectrum influenza vaccine (FLU-v) developed by SEEK: study protocol for a single-center, randomized, double-blind and placebo-controlled clinical phase IIb trial
© The Author(s). 2017
Received: 30 November 2016
Accepted: 24 March 2017
Published: 4 April 2017
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|30 Nov 2016||Submitted||Original manuscript|
|7 Dec 2016||Author responded||Author comments - Eva van Doorn|
|Resubmission - Version 2|
|7 Dec 2016||Submitted||Manuscript version 2|
|28 Feb 2017||Reviewed||Reviewer Report - Victor Huber|
|8 Mar 2017||Reviewed||Reviewer Report - Karl Albert Brokstad|
|21 Mar 2017||Author responded||Author comments - Eva van Doorn|
|Resubmission - Version 3|
|21 Mar 2017||Submitted||Manuscript version 3|
|24 Mar 2017||Editorially accepted|
|4 Apr 2017||Article published||10.1186/s12879-017-2341-9|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting email@example.com. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.